Cancer firm wants to enter Europe and USA with new product – DKK 19 million received for launch

Nanovi has received DKK 19 million (USD 2.8 million) to bring its product to market, first in Europe and then in the USA. The company expects to expand the market for cancer markers, which today is worth more than USD 100 million.

Jesper Boysen, CEO of Nanovi, has raised DKK 19 million for the EU launch of the company's first product. Photo: PR / Nanovi

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles